Skip to main content
Fig. 9 | Diabetology & Metabolic Syndrome

Fig. 9

From: Overall reduced lymphocyte especially T and B subsets closely related to the poor prognosis and the disease severity in severe patients with COVID-19 and diabetes mellitus

Fig. 9

Comparison of B lymphocyte count and percentage among the four subgroups. DM, diabetes mellitus; non-DM, without diabetes mellitus; COVID-19, coronavirus disease 2019. a B lymphocyte count. b B lymphocyte percentage. Unpaired two-way ANOVA was used for interaction comparisons (a, b P allā€‰>ā€‰0.05). Unpaired one-way ANOVA was used for intergroup comparisons (a Pā€‰<ā€‰0.05; b Pā€‰>ā€‰0.05). Unpaired t-tests was used for comparisons with the non-severe non-DM subgroup or between two groups, *Pā€‰<ā€‰0.05, ***Pā€‰<ā€‰0.001. Unpaired t-tests was used for comparisons with the severe non-DM subgroup, ##Pā€‰<ā€‰0.01

Back to article page